PROVECTUS BIOPHARMACEUTICALS, INC. Other Comprehensive Income (Loss), Net of Tax
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) reported Other Comprehensive Income (Loss), Net of Tax of $255 for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2024-11-12
- PROVECTUS BIOPHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for the quarter ending 2024-09-30 was $255.00.
- PROVECTUS BIOPHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for the quarter ending 2024-06-30 was $126.00.
- PROVECTUS BIOPHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for the quarter ending 2024-03-31 was -$415.00, a 317.28% decline year-over-year.
- PROVECTUS BIOPHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for the quarter ending 2023-09-30 was -$441.00.
- PROVECTUS BIOPHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for fiscal 2023 was -$24.49K.
- PROVECTUS BIOPHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$1.21K.
- PROVECTUS BIOPHARMACEUTICALS, INC. other comprehensive income (loss), net of tax for fiscal 2021 was -$370.00.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2024-09-30 | $255.00 10-Q · filed 2024-11-12 | $381.00 derived: sum of 2 quarters · filed 2024-11-12 | -$34.00 derived: sum of 3 quarters · filed 2024-11-12 | |
| 2024-06-30 | $126.00 10-Q · filed 2024-11-12 | -$289.00 derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2024-03-31 | -$415.00 10-Q · filed 2024-11-12 | |||
| 2023-12-31 | -$24.49K 10-K · filed 2024-03-28 | |||
| 2023-09-30 | -$441.00 10-Q · filed 2024-11-12 | -$719.00 derived: sum of 2 quarters · filed 2024-11-12 | -$528.00 derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$278.00 10-Q · filed 2024-11-12 | -$87.00 derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $191.00 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | -$1.21K 10-K · filed 2024-03-28 | |||
| 2022-09-30 | -$1.24K 10-Q · filed 2023-11-14 | -$1.57K derived: sum of 2 quarters · filed 2023-11-14 | -$2.29K derived: sum of 3 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$328.00 10-Q · filed 2023-11-14 | -$1.04K derived: sum of 2 quarters · filed 2023-11-14 | ||
| 2022-03-31 | -$716.00 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | -$370.00 10-K · filed 2023-03-30 | |||
| 2021-09-30 | -$193.00 10-Q · filed 2022-11-09 | -$1.31K derived: sum of 2 quarters · filed 2022-11-09 | -$477.00 derived: sum of 3 quarters · filed 2022-11-09 | |
| 2021-06-30 | -$1.12K 10-Q · filed 2022-11-09 | -$284.00 derived: sum of 2 quarters · filed 2022-11-09 | ||
| 2021-03-31 | $837.00 10-Q · filed 2022-11-09 |